GLP 1

Petrelintide is a long-acting amylin analog being developed by Zealand Pharma as a weekly injectable weight-loss drug.

A partner not on GLP-1 changes your treatment experience in ways no dosing guide mentions.

The Part D redesign is the biggest improvement to Medicare drug coverage in two decades, and for GLP-1 users it’s a genuine but conditional win.

Introduction GLP-1 medications are approved for adolescents in certain situations, and semaglutide is FDA-approved for ages 12 and older with obesity, but whether your…

Does a history of pancreatitis disqualify you from GLP-1 medications? Not automatically, and that surprises people on both sides of the question.

Introduction These overall GLP-1 telehealth rankings 2026 weigh price, price stability, clinical support, product range, and transparency across the platforms Americans actually use. The…

Orforglipron is the oral GLP-1 pill that could change the supply and pricing math of the whole category.

Introduction The oral GLP-1 race is the biggest story in obesity medicine right now, because a pill that works as well as an injection…

One-pan dinners solve a quiet problem of GLP-1 weeks: the cleanup.